Document Detail


Synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of apoptosis on HUVECs by lysophosphatidylcholine.
MedLine Citation:
PMID:  16651717     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lysophosphatidylcholine (LPC), formed during low-density lipoprotein (LDL) oxidation and located within atherosclerotic plaques, regulates a variety of cellular functions, some of which could be construed to promote atherosclerotic lesion development, including vascular muscle cell proliferation, monocyte attraction, and endothelial cell apoptosis. We have previously reported that the synthetic peptide derived from Asp-hemolysin, named P-21, inhibits oxidized LDL (OxLDL)-induced macrophage proliferation through binding of P-21 to OxLDL. In this study, to clarify the interaction between P-21 and LPC as a typical lipid moiety of OxLDL, we examined the influence of P-21 on LPC-induced apoptosis in human umbilical vein endothelial cells (HUVECs). Based on flow cytometric analysis, using annexin V-fluorescein isothiocyanate and propidium iodide as probes to assess apoptosis, LPC induced the apoptosis of HUVECs, and P-21 significantly inhibited this activity by 82.4%. Furthermore, dissociation-enhanced lanthanide fluorometric immunoassay indicated that LPC inhibited the binding of P-21 to OxLDL in a dose-dependent manner. A 50% inhibition dose was estimated to be 4.65 microM of LPC. These results suggest that P-21 inhibits LPC-induced HUVEC apoptosis through binding of P-21 to LPC.
Authors:
Hiromu Tsutsumi; Takeshi Kumagai; Saori Naitoo; Keiichi Ebina; Katsushi Yokota
Related Documents :
18667267 - Induction of apoptosis by furanodiene in hl60 leukemia cells through activation of tnfr...
19666607 - Healthy individuals have t-cell and antibody responses to the tumor antigen cyclin b1 t...
10203687 - Activation of the cd95 (apo-1/fas) pathway in drug- and gamma-irradiation-induced apopt...
23199717 - Dauricine can inhibit the activity of proliferation of urinary tract tumor cells.
24292407 - Incidental gist after appendectomy in a pediatric patient: a first instance and review ...
21815147 - Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum o...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biological & pharmaceutical bulletin     Volume:  29     ISSN:  0918-6158     ISO Abbreviation:  Biol. Pharm. Bull.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-05-02     Completed Date:  2006-07-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9311984     Medline TA:  Biol Pharm Bull     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  907-10     Citation Subset:  IM    
Affiliation:
First Department of Hygienic Chemistry, Tohoku Pharmaceutical University, Sendai, Miyagi, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Annexin A5 / metabolism
Apoptosis / drug effects*
Cell Survival / drug effects
Cells, Cultured
Endothelial Cells / drug effects
Flow Cytometry
Humans
Lipoproteins, LDL / chemistry
Lysophosphatidylcholines / antagonists & inhibitors*,  metabolism,  pharmacology*
Oxidation-Reduction
Protein Binding
Chemical
Reg. No./Substance:
0/Annexin A5; 0/Lipoproteins, LDL; 0/Lysophosphatidylcholines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
Next Document:  Vibrio vulnificus vulnibactin, but not metalloprotease VvpE, is essentially required for iron-uptake...